NUWE.NASDAQNuwellis, INC

8-K: Nuwellis Regains Nasdaq Compliance, Averting Delisting

Sentiment:

Listing Compliance Update


Nuwellis, Inc. announced it has regained compliance with Nasdaq's minimum bid price requirement, leading to the cancellation of its delisting hearing and continued listing on The Nasdaq Capital Market.

Better than expectedNuwellis successfully cured its minimum bid price deficiency, avoiding delisting from Nasdaq.The scheduled delisting hearing was cancelled, confirming the company's continued listing.

Summary

  • Nuwellis, Inc. received a notice from Nasdaq on June 18, 2025, indicating its common stock bid price had fallen below $1.00 for 30 consecutive trading days.
  • Due to prior reverse stock splits with a cumulative ratio of 250 shares or more to one within the last two years, the company was not eligible for the standard compliance period and faced immediate delisting unless a hearing was requested.
  • Nuwellis timely requested a hearing before the Nasdaq Hearings Panel, which was scheduled for August 12, 2025.
  • On July 22, 2025, the company received a letter from the Nasdaq Office of General Counsel confirming that the minimum bid price deficiency had been cured.
  • As a result, Nuwellis is now in compliance with Nasdaq's listing standards, the scheduled hearing was deemed moot and cancelled, and Nasdaq will continue the listing of the company's common stock on The Nasdaq Capital Market.

Sentiment

Score: 8

Explanation: The sentiment is highly positive as the company successfully resolved a significant delisting threat, ensuring its continued presence on a major stock exchange. This removes a major overhang for investors.

Positives

  • Nuwellis has successfully cured its minimum bid price deficiency and is now in compliance with Nasdaq listing standards.
  • The scheduled delisting hearing before the Nasdaq Hearings Panel has been cancelled.
  • The company's common stock will continue to be listed on The Nasdaq Capital Market, avoiding delisting.

Negatives

  • The company previously failed to meet Nasdaq's minimum bid price requirement, with its stock closing below $1.00 for 30 consecutive trading days.
  • Nuwellis was not eligible for a standard compliance period due to having effected one or more reverse stock splits with a cumulative ratio of 250 shares or more to one within the prior two-year period.

Risks

  • Risk of delisting from Nasdaq due to failure to maintain the minimum bid price requirement, which has now been mitigated.

Future Outlook

The filing indicates that Nuwellis has resolved its Nasdaq listing compliance issue, ensuring its continued listing on The Nasdaq Capital Market. No other forward-looking statements or guidance regarding financial performance or strategic initiatives are provided.

Management Comments

  • John L. Erb, President and Chief Executive Officer, signed the report on behalf of Nuwellis, Inc.

Industry Context

Maintaining a listing on a major exchange like Nasdaq is crucial for publicly traded companies as it provides liquidity, visibility, and access to capital markets. Failure to meet listing standards, such as minimum bid price, can lead to delisting, which often results in reduced investor confidence, lower stock prices, and limited access to institutional investors. Nuwellis's successful resolution of this issue ensures it retains these benefits.

Stakeholder Impact

  • Shareholders: Avoided potential delisting, which typically leads to reduced liquidity and investor interest. Continued listing on Nasdaq maintains market access and visibility for shareholders.

Next Steps

  • Continued listing of Nuwellis's common stock on The Nasdaq Capital Market.

Key Dates

DateDescription
2025-06-18Nuwellis, Inc. received notice from Nasdaq regarding its common stock bid price closing below $1.00 per share for 30-consecutive trading days.
2025-07-22Nuwellis, Inc. received a letter from the Nasdaq Office of General Counsel notifying the company that the minimum bid price deficiency had been cured and that the company was in compliance with applicable listing standards.
2025-07-23Date the Form 8-K report was signed by Nuwellis, Inc.
2025-08-12Original scheduled date for the hearing before the Nasdaq Hearings Panel, which was subsequently cancelled.

Keywords

Nuwellis, NUWE, Nasdaq, delisting, compliance, minimum bid price, stock market, listing standards, reverse stock split, corporate governance

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.